The myocilin/trabecular meshwork-inducible glucocorticoid response (MYOC/TIGR) gene was identified as a gene that caused open angle glaucoma (OAG). Singlestrand conformation polymorphism analysis and subsequent sequence analysis were performed for the MYOC/ TIGR gene in 120 unrelated Japanese OAG patients with increased intraocular pressure (IOP), 116 unrelated OAG patients without increased IOP, and 106 unrelated control subjects without glaucoma. An Arg158Gln sequence change in the leucine zipper-like motif (LZM) region in the myosin-homology domain was found in 2 OAG patients with or without increased IOP, and in a 56-year-old control subject without glaucoma. This is the first report of missense sequence change in the LZM region of the MYOC/TIGR protein in subjects showing various phenotypes, including a control subject. These findings suggest that Arg158Gln in the LZM region is probably a rare nondisease-causing polymorphism, despite its important role in this region, because it was found in a control subject, although Arg158Gln was previously reported as a probable diseasecausing mutation.
Introduction
Glaucoma is one of the most common eye diseases and can potentially result in bilateral blindness. It was estimated that nearly 66.8 million people worldwide would be affected by glaucoma by the year 2000 (Quigley 1996) . The disease is characterized by an excavated optic nerve head and the progressive loss of visual field.
The myocilin/trabecular meshwork-inducible glucocorticoid response (MYOC/TIGR) gene was identified as a gene that caused open angle glaucoma (OAG) (Stone et al. 1997) . It consists of three exons and encodes 504 amino acid residues (Adam et al. 1997) . The amino acid sequence is highly homologous to the myosin in the N-terminal region and to the olfactomedin in the C-terminal region (Kubota et al. 1997) . The myosin-homology domain contains a leucine zipper-like motif (LZM) (Kubota et al. 1997) , and this kind of motif found in the tropomyosin-like zipper protein is thought to be involved in interactions with myosin (Bikle et al. 1993) . These findings suggest that LZM in the MYOC/ TIGR protein may play an important role in maintaining the normal function of the MYOC/TIGR protein. Kubota et al. (2000) reported that missense sequence change (Arg158Gln) in this motif region was probably responsible for OAG, although the olfactomedin-homology domain of the MYOC/TIGR protein appears to be the focus of pathogenic mutations in patients with OAG (Adam et al. 1997) . In this study, we found Arg158Gln in subjects showing various phenotypes, including a control subject without glaucoma, we report the genotype and phenotypes of these patients.
Subjects and methods

Subjects
Informed consent was obtained and peripheral blood was collected from 120 unrelated Japanese OAG patients with increased intraocular pressure (IOP), 116 unrelated Japanese OAG patients without increased IOP, and 106 unrelated Japanese control subjects without glaucoma. The study protocol was approved by the Ethics Committee of Yamanashi Medical University. The age at diagnosis in the OAG patients with increased IOP ranged from 13 to 87 years (mean Ϯ SD, 53.1 Ϯ 15.9 years), and the age in the OAG patients without increased IOP ranged from 22 to 84 years (mean Ϯ SD, 59.0 Ϯ 13.1 years). In the OAG patients with increased IOP, 27 patients had a family history of glaucoma (22.5%), and in the OAG patients without increased IOP, 24 patients had a family history of glaucoma (20.7%). The mean maximum known IOP was 29.3 Ϯ 9.9 mmHg (range, 22 to 74 mmHg) in the OAG patients with increased IOP, and the mean maximum known IOP was 18.6 Ϯ 1.9 mmHg (range 14 to 21 mmHg) in the OAG patients without increased IOP. The age in control subjects ranged from 41 to 84 years (mean Ϯ SD, 64.8 Ϯ 11.1 years); their mean maximum known IOP was 15.0 Ϯ 2.8 mmHg (range 8 to 20 mmHg) ( Table 1 ).
Mutation analysis
Genomic DNA was purified with a DNA Extractor WB Kit (Wako, Osaka, Japan), and screened for the MYOC/TIGR gene mutations, using single-strand conformation polymorphism (SSCP) analysis. The three exons of the MYOC/ TIGR gene were amplified by dividing the two longer exons into overlapping polymerase chain reaction (PCR) products. The 13 PCR amplicons were obtained using the primer pairs reported by Alward et al. (1998) . The PCR reactions were carried out in a total volume of 20µl, containing 100ng genomic DNA, 4 pmol of each primer, 0.2mM of each dNTP, 1.5 mM of MgCl 2 , and 0.5U of Taq polymerase (TaKaRa Taq; Takara, Tokyo, Japan) in a thermocycler (model AB-1820; ATTO, Tokyo, Japan). Amplification was carried out with an initial denaturation at 94°C for 5 min, followed by 25 cycles of denaturation at 94°C for 30 s, annealing at 55°C for 30 s, and extension at 72°C for 1 min. A final extension at 72°C for 7 min completed the reactions. After amplification, 4 µl of stop solution (90% formamide, 5 mM ethylenediamine tetraacetic acid (EDTA), 0.05% bromophenol blue, 0.05% xylene cyanol) was added to 4 µl of each sample. Amplification products were loaded on polyacrylamide gels (GeneGel Excel 12.5/24 Kit; stacking gel, T ϭ 6%; C ϭ 3%; separating gel, T ϭ 12.5%; C ϭ 2%; Amersham Pharmacia Biotech, Amersham Place, UK), after denaturation for 5 min at 95°C, and electrophoresed at 20 W for 1 h and 40min at the most appropriate temperature for amplification products (5°C, 10°C, or 15°C), using an electrophoresis unit (GenePhor; Amersham Pharmacia Biotech). After the electrophoresis, the gels were stained with silver nitrate in an automated gel stainer (Hoefer; Amersham Pharmacia Biotech). Abnormal PCR products identified by SSCP analysis were sequenced using fluorescent dideoxynucleotides in an automated sequencer (model 310; ABI Prism Biosystem, Foster City, CA, USA). All sequencing was bidirectional.
Results
Of the 236 OAG patients, 2 had a heterozygous G-to-A change at nucleotide 473 in the first exon of the MYOC/ TIGR gene, resulting in an amino acid change from arginine to glutamine: Arg158Gln (Fig. 1 ). This sequence change was also found in 1 of the 106 control subjects without glaucoma. These 3 subjects simultaneously had heterozygous G-to-A changes at 83 bp upstream of the promoter site and at nucleotide 227, resulting in an amino acid change from arginine to lysine: Arg76Lys, which was found in 14 of the 236 patients with OAG and in 8 of the 106 control subjects.
Case 1
A 43-year-old man with no family history of glaucoma had had blurred vision in his right eye at the age of 38, when the IOP was high in both eyes. He was referred to us because of insufficient reduction in IOP despite his having used topical antiglaucoma medications. At the initial examination, his best corrected visual acuity was 1.2 in each eye. His IOP was 23 mmHg in the right eye and 28 mmHg in the left eye with 0.5% timolol maleate (Timoptol; Banyu, Tokyo, Japan) and 0.1% dipivefrine hydrochloride (Pivalephrine; Santen, Osaka, Japan) twice daily. Gonioscopy revealed a widely Fig. 2A,B) , he was diagnosed with OAG because his maximum known IOP was remarkably high (36 mmHg).
Case 2
A 76-year-old woman was seen in 1998, when she complained of visual loss. She had no family history of glaucoma. At the initial examination at the age of 74, her best corrected visual acuity in the right eye had been hand motion, because of cataract, and 1.0 in the left. After cataract surgery, her best corrected visual acuity in the right eye improved to 1.0. Ophthalmoscopic examination revealed moderately excavated optic discs in both eyes, with a splinter hemorrhage at the inferotemporal edge of the left optic disc (Fig. 3A,B ). HFA30-2 showed an altitudinal visual field defect in the right eye and an arcuate defect in the left eye (Fig. 3A,B) . Gonioscopy revealed a widely open angle in both eyes. The IOP never exceeded 16mmHg, without medication, and the visual field defects were stable during the following 2 years. An X-ray computerized tomography study revealed no signs of intracranial disease that would cause visual field defects. She was diagnosed with OAG without increased IOP.
Case 3
A 56-year-old man with mild cataract with no family history of glaucoma served as a normal control subject. His best corrected visual acuity was 1.0 in each eye. No signs of glaucoma were found in the optic disc in either eye, with an IOP of 13 mmHg in his right eye and an IOP of 15mmHg in his left eye. The family members
The family members of these three individuals (cases 1, 2, and 3) were requested to undergo ophthalmoscopic and genetic studies. Only one of the five children of case 2, a 49-year-old man, was studied. His IOP was 14 mmHg in the right eye and 13 mmHg in the left eye, with no glaucomatous changes in the optic disc in either eye. He did not have the Arg158Gln sequence change in the MYOC/TIGR protein.
Discussion
Twelve amino acid sequence changes in the MYOC/TIGR protein have been reported in Japanese patients with OAG (Suzuki et al. 1997; Fingert et al. 1999; Yokoyama et al. 1999; Kawase et al. 2000; Kubota et al. 2000) . Of these 12 sequence changes, 5 were found only in Japanese. Arg158Gln may also be a specific sequence change in Japanese, because it has not been found, despite the screening of more than 2000 patients with OAG and more than 1000 control subjects, in other ethnic groups (Adam et al. 1997; Stoilova et al. 1997 Stoilova et al. , 1998 Allingham et al. 1998; Angius et al. 1998; Brezin et al. 1998; Kennan et al. 1998; Michels-Rautenstrauss et al. 1998; Morissette et al. 1998; Richards et al. 1998; Wiggs et al. 1998; Damji et al. 1999; Fingert et al. 1999; Yoon et al. 1999; Lam et al. 2000) . Arg158Gln was reported as a probable disease-causing mutation because it has previously been found only in a 12-year-old OAG patient without increased IOP (Kubota et al. 2000) . The MYOC/TIGR protein contains an LZM, which consists of two subgroups (amino acid residues 85-99 and 117-166) in which leucine residues appear three and eight times, respectively, at every seventh position (Adam et al. 1997) . Arg158Gln occurs in the latter subgroup of LZM and may be responsible for OAG, by preventing the normal function of the LZM by altering the charge in this motif region. The LZM is considered to play an important role in the interaction between proteins, in polymerization as well as dimerization (Alber 1992) . Previous studies have reported that kidney renin-binding protein with mutations in the LZM neither bound to renin nor formed a homodimer (Inoue et al. 1991) , and that mutations in the LZM of human immunodeficiency virus type 1 gp41 dominantly inhibited infectious virus production . Because MYOC/TIGR proteins are thought to form homodimers , it is possible that Arg158Gln may interfere with their dimerization.
However, in this study, Arg158Gln was found not only in two OAG patients but also in a 56-year-old control subject without glaucoma, which means that Arg158Gln is probably a rare non-disease-causing polymorphism that just happens to alter the amino acid structure of the MYOC/TIGR protein, as it was found in a control subject. Mouse and rat have Gln in this position, and this observation supports the nondisease-causing polymorphic nature of this amino acid change in codon 158.
Although these findings suggest that Arg158Gln in the LZM region of the MYOC/TIGR protein is not responsible for OAG, despite its important role in this region, other missense sequence changes without Arg158Gln in this motif region, especially a sequence change in the leucine residue composing zipper-like motif, may be responsible for OAG. Further investigation will be needed to elucidate the effect of amino acid sequence changes in the LZM region of the MYOC/TIGR protein.
